Financial News
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock (NQ:CYCCP)
All News about Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock

From Cyclacel
Via GlobeNewswire




Cyclacel Pharmaceuticals to Release Third Quarter 2022 Financial Results
November 03, 2022
From Cyclacel
Via GlobeNewswire










Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.